Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)

Grants and Contracts Details

Description

Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
StatusFinished
Effective start/end date9/4/208/31/23

Funding

  • Atrium Health: $2.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.